Methenamine hippurate
CAS: 5714-73-8
Ref. 3D-FM30937
| 1g | 483.00 € | ||
| 2g | 693.00 € | ||
| 100mg | 115.00 € | ||
| 250mg | 204.00 € | ||
| 500mg | 329.00 € |
Product Information
- 1,3,5,7-Tetraazatricyclo[3.3.1.1<sup>3,7</sup>]decane, compd. with N-benzoylglycine (1:1)
- Glycine, N-benzoyl-, compd. with 1,3,5,7-tetraazatricyclo[3.3.1.1<sup>3,7</sup>]decane (1:1)
- Haiprex
- Hexamethylenetetramine hippurate
- Hexamethylenetetramine hippuric acid complex
- Hexamethylenetetramine, monohippurate
- Hexamine hippurate
- Hippramine
- Hippuric acid, compd. with hexamethylenetetramine (1:1)
- Hiprex
- See more synonyms
- Methenamine Hippurate
- N-benzoylglycine - 1,3,5,7-tetraazatricyclo[3.3.1.1~3,7~]decane (1:1)
- R-657
- Viapta
Methenamine hippurate is a drug that has been used in the treatment of urinary tract infections. It is also used to prevent recurrence of these infections. Methenamine hippurate works by releasing formaldehyde, which inhibits the growth of bacteria by affecting their cell membrane. The release of formaldehyde is dependent on the concentration of methenamine and the pH, with a pH range from 7.0 to 8.5 being most effective for inhibiting bacterial growth. The release of formaldehyde can be inhibited by adding an acid to the urine sample or by adding hippurate to methenamine hippurate. Methenamine hippurate may cause drug interactions with other drugs that are eliminated through the kidneys, such as acetaminophen, sulfonamides, and indomethacin. This drug also has been shown to have therapeutic effects on choroidal neovascularization and geriatric patients with urinary tract infections.!--
END-->
Chemical properties
Technical inquiry about: 3D-FM30937 Methenamine hippurate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
